Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

The treatment was ineffective in humans.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Cells from certain embryo parts can induce head formation in another embryo, involving complex signaling pathways.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Testosterone's muscle-building effects do not require its conversion to DHT.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Cancer treatments often cause skin, nail, and hair problems.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Sonic hedgehog signaling is crucial for hair growth and maintaining hair follicle identity.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.